← Back to catalogue

Haemonetics Mcs+ (ln9000) Apheresis System

FDA UDI

Class II (US FDA UDI)

by Haemonetics Corporation

Identity

Trade Name
HAEMONETICS MCS+ (LN9000) APHERESIS SYSTEM FDA UDI
Generic Name
Apheresis system FDA UDI
Device Name
MCS+ ,110V ENGL, LN 09000-110-E FDA UDI
Model / Reference
09000-110-E FDA UDI
Description
MCS+ ,110V ENGL, LN 09000-110-E FDA UDI

Identifiers

Primary DI / UDI-DI
30812747012816 FDA UDI
FDA Product Code
GKT FDA UDI
GMDN Term
Apheresis system FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.9245 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Apheresis system

Haemonetics Mcs+ (ln9000) Apheresis System by Haemonetics Corporation — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Apheresis system.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 1a53de9c-0104-46b4-8066-b46ebea097ee 35 fields · synced Jun 8, 2026